Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-engraftment Cytomegalovirus DNAemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Incidence, Risk Factors and Clinical Outcomes

NCT03889028 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.

NCT NCT03889028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-engraftment Cytomegalovirus DNAemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Incidence, Risk Factors and Clinical Outcomes
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Phase
Observational
Overall status
Completed
Start date
September 2, 2019
Completion date
September 1, 2020
Enrollment
878 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cmv dnaemia pre-engraftment